Erbe USA Incorporated
11
1
4
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
9.1%
1 terminated/withdrawn out of 11 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
50%
3 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Cryoprobe Versus Forceps for Transbronchial Biopsy
Role: collaborator
Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy
Role: collaborator
Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity
Role: collaborator
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
Role: collaborator
Feasibility of Performing Peripheral Pulmonary Lesion Biopsy Using Robotic Bronchoscopy-Guided Cryoprobe
Role: collaborator
Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study
Role: collaborator
Post-resection Treatment of Large Colon Polyps
Role: collaborator
Safety of a Sheath Cryoprobe Bronchoscopic Transbronchial Biopsy Technique
Role: collaborator
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2
Role: collaborator
Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique
Role: collaborator
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy
Role: collaborator
All 11 trials loaded